Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × fludarabine phosphate × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Myelodysplastic Syndromes 14 Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Non-Hodgkin 9 Multiple Myeloma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Lymphoma, Large B-Cell, Diffuse 7 Hematologic Neoplasms 7 Lymphoma, Mantle-Cell 6 Lymphoma, Follicular 6 Lymphoma 6 Leukemia, Biphenotypic, Acute 6 Leukemia 6 Hodgkin Disease 6 Melanoma 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, B-Cell 4 Leukemia, Myelomonocytic, Chronic 4 Hematologic Diseases 4 Myeloproliferative Disorders 3 Lymphoproliferative Disorders 3 Leukemia, Lymphoid 3 Leukemia, B-Cell 3 Anemia, Refractory, with Excess of Blasts 3 Uveal Melanoma 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Primary Myelofibrosis 2 Preleukemia 2

Interventions

Gemcitabine 35 130-nm albumin-bound paclitaxel 20 pembrolizumab 18 Specimen Handling 18 Magnetic Resonance Spectroscopy 17 Fluorouracil 16 Leucovorin 15 Irinotecan 15 Taxes 14 Oxaliplatin 14 Albumin-Bound Paclitaxel 14 Biopsy 13 Cyclophosphamide 10 fludarabine 9 Carboplatin 7 dehydroftorafur 6 Cetuximab 6 olaparib 5 Radiosurgery 5 defactinib 4 aldesleukin 4 Radiotherapy 4 Pancreatectomy 4 Cisplatin 4 trastuzumab deruxtecan 3 niraparib 3 irinotecan sucrosofate 3 atezolizumab 3 Pemetrexed 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06898385 2026-01-08

IX001 TCR-T

Sun Yat-sen University

Phase 1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡